Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Resource Utilization and Cost Analysis of a Chromogenic Factor X Assay for Anticoagulation Monitoring and Management

Ronak Mistry, Ameet Patel, Benjamin F. Tillman

Blood (2022) 140 (Supplement 1): 10761–10762.

https://doi.org/10.1182/blood-2022-167324

Published: 2022

Journal Articles

Evaluation of Cost Drivers and Cost-Efficacy of Autologous Hematopoietic Transplant and Chimeric Antigen Receptor T-Cell Therapy in High-Grade B Cell Lymphoma from a Healthcare Firm Perspective

Ameet Patel, Jayant Bagai, Deidra A Dickerson, Kristen Muncy, Brittney M Baer, Nancy Long, Bipin Savani, Bhagirathbhai Dholaria, Burch Wood, Olalekan O. Oluwole

Blood (2022) 140 (Supplement 1): 13082–13084.

https://doi.org/10.1182/blood-2022-157181

Published: 2022

Journal Articles

Reduction in Prevalence of Thrombotic Events in Sickle Cell Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Ameet Patel, MD, Karina L Wilkerson, NP, MSN, Kathryn A. Culos, PharmD, Jennifer Green, MD, Michael T. Byrne, DO, Salyka M. Sengsayadeth, MD, Bhagirathbhai Dholaria, MBBS, Bipin N. Savani, MD, Stacey Ann Goodman, MD, Wichai Chinratanalab, MD, Reena Jayani, MD, Katie S. Gatwood, PharmD, Brian G. Engelhardt, MD, Adetola A. Kassim, MDMS

Blood (2020) 136 (Supplement 1): 12.

https://doi.org/10.1182/blood-2020-138499

Published: 2020

Journal Articles

Peripheral Blood Blast Clearance As an Independent Predictor of Clinical Response and Outcomes in Acute Myeloid Leukemia

Noa G. Holtzman, MD, Firas El Chaer, MD, Omer Ali, MD, Ameet Patel, MD, Maria R. Baer, MD, Vu H. Duong, MD, Edward A. Sausville, MD PhD, Arash Etemadi, MD PhD, Ashkan Emadi, MD PhD

Blood (2018) 132 (Supplement 1): 2684.

https://doi.org/10.1182/blood-2018-99-115512

Published: 2018

Journal Articles

Impact of Body Mass Index (BMI) on Survival Endpoints in Multiple Myeloma

Mehmet Hakan Kocoglu, MD, Ameet Patel, MD, Aaron P. Rapoport, MD, Ning Ma, CRNP, Jennifer Ding, MD, Simran Elder, MD BA, Aneesha Hossain, MD, Ashraf Z. Badros, MD

Blood (2018) 132 (Supplement 1): 5750.

https://doi.org/10.1182/blood-2018-99-117915

Published: 2018

Journal Articles

Use of Direct Oral Anticoagulants in Patients with Sickle Cell Disease and Venous Thromboembolism Is Associated with a Significant Decrease in Incidence of Bleeding Compared to Vitamin K Antagonists and Low-Molecular-Weight Heparins

Ameet Patel, MD, Hants Williams, PhD, Maria R. Baer, MD, Ann Butler Zimrin, MD, Jennie Y Law, MD

Blood (2017) 130 (Supplement 1): 978.

https://doi.org/10.1182/blood.V130.Suppl_1.978.978

Published: 2017

NARROW

Resource Utilization and Cost Analysis of a Chromogenic Factor X Assay for Anticoagulation Monitoring and Management

Evaluation of Cost Drivers and Cost-Efficacy of Autologous Hematopoietic Transplant and Chimeric Antigen Receptor T-Cell Therapy in High-Grade B Cell Lymphoma from a Healthcare Firm Perspective

Reduction in Prevalence of Thrombotic Events in Sickle Cell Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Peripheral Blood Blast Clearance As an Independent Predictor of Clinical Response and Outcomes in Acute Myeloid Leukemia

Impact of Body Mass Index (BMI) on Survival Endpoints in Multiple Myeloma

Use of Direct Oral Anticoagulants in Patients with Sickle Cell Disease and Venous Thromboembolism Is Associated with a Significant Decrease in Incidence of Bleeding Compared to Vitamin K Antagonists and Low-Molecular-Weight Heparins

Email alerts

ASH Publications

American Society of Hematology

Resource Utilization and Cost Analysis of a Chromogenic Factor X Assay for Anticoagulation Monitoring and Management

Evaluation of Cost Drivers and Cost-Efficacy of Autologous Hematopoietic Transplant and Chimeric Antigen Receptor T-Cell Therapy in High-Grade B Cell Lymphoma from a Healthcare Firm Perspective

Reduction in Prevalence of Thrombotic Events in Sickle Cell Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Peripheral Blood Blast Clearance As an Independent Predictor of Clinical Response and Outcomes in Acute Myeloid Leukemia

Impact of Body Mass Index (BMI) on Survival Endpoints in Multiple Myeloma

Use of Direct Oral Anticoagulants in Patients with Sickle Cell Disease and Venous Thromboembolism Is Associated with a Significant Decrease in Incidence of Bleeding Compared to Vitamin K Antagonists and Low-Molecular-Weight Heparins

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only